4//SEC Filing
Pinnow Cole 4
Accession 0000950170-25-005630
CIK 0001622229other
Filed
Jan 14, 7:00 PM ET
Accepted
Jan 15, 7:00 AM ET
Size
5.3 KB
Accession
0000950170-25-005630
Insider Transaction Report
Form 4
Pinnow Cole
Chief Commercial Officer
Transactions
- Purchase
Common Stock
2025-01-14$7.60/sh+43,750$332,413→ 45,848 total
Footnotes (2)
- [F1]The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $7.53 to $7.60. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
- [F2]Includes an aggregate of 1,398 shares acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan on December 31, 2024.
Documents
Issuer
Cogent Biosciences, Inc.
CIK 0001622229
Entity typeother
Related Parties
1- filerCIK 0002024135
Filing Metadata
- Form type
- 4
- Filed
- Jan 14, 7:00 PM ET
- Accepted
- Jan 15, 7:00 AM ET
- Size
- 5.3 KB